Glenmark Pharmaceuticals recommends dividend of Rs. 2.50

The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on May 27, 2022, has recommended Dividend @ 250% i.e. Rs. 2.50/- per share (face value of Re. 1/- each) on the Equity Share Capital of the Company for the financial year 2021- 22 subject to the approval of the Shareholders at the ensuing Annual General Meeting.

Shares of Glenmark Pharmaceuticals Limited was last trading in BSE at Rs. 398.05 as compared to the previous close of Rs. 393.60. The total number of shares traded during the day was 131445 in over 2464 trades.

The stock hit an intraday high of Rs. 402.45 and intraday low of 391.90. The net turnover during the day was Rs. 52051203.00.

Source : Equity Bulls

Keywords

GlenmarkPharmaceuticals INE935A01035 Dividend FY2022